STOCK TITAN

UNITY Biotechnology to Participate in Upcoming September Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

UNITY Biotechnology (NASDAQ: UBX), focused on therapeutics addressing aging diseases, announced participation in three September investor conferences. These include the Citi 15th Annual BioPharma Virtual Conference on September 9, the Morgan Stanley 18th Annual Global Healthcare Conference on September 15 at 4:15 PM E.T., and the Cantor Fitzgerald Virtual Healthcare Conference on September 16 at 10:00 AM E.T. Webcasts of the events will be available on the Investor & Media section of UNITY’s website, with replays accessible for 90 days.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate in the following upcoming September investor conferences:

Citi 15th Annual BioPharma Virtual Conference
Date: September 9, 2020
Location: Virtual – 1x1 only

Morgan Stanley 18th Annual Global Healthcare Conference
Date: September 15, 2020
Fireside Chat Time: 4:15 PM E.T.
Location: Virtual

Cantor Fitzgerald Virtual Healthcare Conference Conference
Date: September 16, 2020
Presentation Time: 10:00 AM E.T.
Location: Virtual

A live audio webcast of the fireside chat and presentation from the Morgan Stanley and Cantor Fitzgerald conferences will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following each event.

About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related diseases, such as osteoarthritis, eye diseases, neurological diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors 
Endurance Advisors
Mike Zanoni
  

Media 
Canale Communications
Jason Spark

FAQ

What conferences is UNITY Biotechnology attending in September 2020?

UNITY Biotechnology will attend the Citi BioPharma Virtual Conference on September 9, the Morgan Stanley Global Healthcare Conference on September 15, and the Cantor Fitzgerald Healthcare Conference on September 16, 2020.

When is the Morgan Stanley Global Healthcare Conference for UNITY?

The Morgan Stanley Global Healthcare Conference will take place on September 15, 2020, with a fireside chat at 4:15 PM E.T.

How can I access webcasts of UNITY's conference presentations?

Live audio webcasts of UNITY's presentations will be available on their website's Investors & Media section and archived for 90 days after each event.

What is the focus of UNITY Biotechnology's therapeutics?

UNITY Biotechnology is focused on developing therapeutics that aim to slow, halt, or reverse diseases related to aging, including osteoarthritis and neurological diseases.

What date is the Cantor Fitzgerald Virtual Healthcare Conference?

The Cantor Fitzgerald Virtual Healthcare Conference will be held on September 16, 2020, with a presentation at 10:00 AM E.T.

Unity Biotechnology, Inc.

NASDAQ:UBX

UBX Rankings

UBX Latest News

UBX Stock Data

16.67M
16.63M
1.31%
20.55%
1.71%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO